Rabbit Anti-GPR146 Recombinant Antibody (EG1380) (CBMAB-EN1659-LY)

Al Mahri, S., Okla, M., Rashid, M., Malik, S. S., Iqbal, J., Al Ibrahim, M., ... & Mohammad, S. (2023). Profiling of G-protein Coupled Receptors in Adipose Tissue and Differentiating Adipocytes Offers a Translational Resource for Obesity/Metabolic Research. Cells, 12(3), 377.

Wilkins, B. P., Finch, A. M., Wang, Y., & Smith, N. J. (2022). Orphan GPR146: an alternative therapeutic pathway to achieve cholesterol homeostasis?. Trends in Endocrinology & Metabolism.

Bray, L., Caillaud, A., Girardeau, A., Patitucci, M., Le May, C., Cariou, B., & Rimbert, A. (2022). Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1). Stem Cell Research, 60, 102721.

Rimbert, A., Yeung, M. W., Dalila, N., Thio, C. H., Yu, H., Loaiza, N., ... & Kuivenhoven, J. A. (2022). Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile. Arteriosclerosis, thrombosis, and vascular biology, 42(10), 1262-1271.

Loaiza, N. (2022). Functional Insights Into Novel Regulators of Plasma Lipids: STAP1 and GPR146.

Brachs, S., Mai, K., Sbierski-Kind, J., Klockgeter, J., Harutyunyan, A., Liu, A., ... & Spranger, J. (2022). A metabolically-healthy lean phenotype is sustained in GPR146-deficient mice during diet-induced obesity. Diabetologie und Stoffwechsel, 17(S 01), P-100.

Fernández-Ruiz, I. (2020). GPR146 is a potential new therapeutic target for lipid lowering. Nature Reviews Cardiology, 17(3), 132-133.

She, L., Yao, H., He, L., Li, Y., & Cao, J. (2020). GPR146: an emerging therapeutic target for hypercholesterolemia and atherosclerosis. Acta Biochimica et Biophysica Sinica, 52(8), 914-915.

Yu, H., Rimbert, A., Palmer, A. E., Toyohara, T., Xia, Y., Xia, F., ... & Cowan, C. A. (2019). GPR146 deficiency protects against hypercholesterolemia and atherosclerosis. Cell, 179(6), 1276-1288.

Yu, H., Rimbert, A., Palmer, A., Toyohara, T., Xia, Y., Xia, F., ... & Cowan, C. (2019). Orphan Receptor GPR146 Deficiency Reduces Plasma Cholesterol Levels and Protects Against Atherosclerosis. Circulation, 140(Suppl_1), A12855-A12855.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Isotype control